Table 3.
HU Counseling (N = 43) | Nonadherent (n = 12) | Adherent (n = 31) | |
---|---|---|---|
Lack of familiarity with recommendation | 3 (7%) | 0 | 3 |
Lack of agreement with recommendation* | 5 (12%) | 4 | 1 |
Lack of self-efficacy | |||
To recognize which patients may benefit from HU | 13 (30%) | 6 | 7 |
To prescribe appropriate dose and schedule of HU | 12 (28%) | 6 | 6 |
To recognize side effects of HU | 12 (28%) | 6 | 6 |
To discuss risk of possible HU side effects with patients/parents | 16 (37%) | 7 | 9 |
To at least one of the above (eg, recognize which patients may benefit, prescribe HU, recognize side effects, or discuss HU risk) | 21 (49%) | 8 | 13 |
Lack of outcome expectancy | 19 (44%) | 7 | 12 |
Presence of external barriers | |||
Lack of equipment or space | 3 (7%) | 2 | 1 |
Lack of time | 6 (14%) | 2 | 4 |
Lack of educational materials | 6 (14%) | 3 | 3 |
Lack of support staff* | 7 (16%) | 5 | 2 |
Lack of reimbursement | 5 (12%) | 3 | 2 |
Other issues | 1 (2%) | 0 | 1 |
Lack of one or more of the above* | 13 (30%) | 7 | 6 |
Abbreviation: HU, hydroxyurea.
P < .05 based on Fisher’s exact test.